Skip to content
DataLookout
Menu

NCT07896486

Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Start date changed from estimate of Sep 2026 to Nov 4, 2026
    • Site details revised
  2. Minor Study title shortened, about 16 words
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change from baseline in PIH of the face at Week 12, as assessed by the Post-Acne Hyperpigmentation Index (PAHPI) score
Timeframe: Baseline; 12 weeks

Secondary (2)

Number or participants who tolerated the investigational product as assessed by the investigator
Patient-reported stigmatization, as measured by the PUSH-D questionnaire at week 12

Arms and interventions

Participants with Acne-Associated Post-Inflammatory Hyperpigmentation using the Vinoperfect SerumOther

Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.

Other: Vinoperfect brightening serum

Sites

1 site in 1 country

  • Weill Cornell Medicine DermatologyNew York, New York, United States